This week, the top stories in managed care included Aetna's announcement that it was pulling back its participation on the Affordable Care Act exchanges, the annual meeting of the American Association of Diabetes Educators outlined how existing sites can help roll out the Diabetes Prevention Program nationwide, and hospital leaders gave their opinions on CMS' hospital readmission program.
Hello, I’m Justin Gallagher, associate publisher of The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network.
Aetna Withdraws From Some Exchanges
Aetna announced this week that it is leaving 11 states where it sells coverage on the marketplace exchanges, and that in 2017 it will reduce its footprint from 778 to 242 counties.
Like other insurers, including United Healthcare, Aetna cited $430 million in losses from patients who are newly insured under the Affordable Care Act (ACA). These patients are sicker than expected, and some cancel their policies after running up large healthcare bills. Aetna also cited problems with the ACA’s financial protection tools, such as risk corridors, that were underfunded by Congress.
While several markets face limited competition in 2017, Aetna’s move took many by surprise because it had supported the exchanges. Critics of Aetna are unhappy that it wants to leave the exchanges while keeping its contracts for Medicaid and Medicare.
And news reports suggest that Aetna is acting in response to the Justice Department’s opposition to its merger with Humana.
Diabetes Prevention
The existing system of 3500 sites where patients receive diabetes self-management education could be leveraged to offer the Diabetes Prevention Program to millions with prediabetes. A plan to tap this network was a highlight of the annual meeting of the American Association of Diabetes Educators, held in San Diego.
Joanna Craver DiBenedetto, director of prevention for AADE, said the existing sites offer several advantages:
Read all of our coverage from the AADE annual meeting.
Journal Cancer Cover
A study in the journal CANCER highlights the need for ongoing surveillance after someone is first diagnosed with the disease. Research at UCLA found that 1 in 12 people who survive a common cancer will develop a second, unrelated malignancy, and this second bout is often more deadly.
Among those who developed a second cancer, 13% died of their primary cancer and 55% died of their secondary cancer. Researchers followed two million adults with 10 common cancers. The most common secondary cancer was lung cancer, especially in patients who smoke.
CMS Readmission Program
A CMS program that charges hospitals penalties for higher-than-expected 30-day readmission rates is having major effects on healthcare delivery, according to a survey in the new issue of The American Journal of Managed Care.
Nearly two-thirds of the hospital leaders who answered the survey said the rules have a “significant” or “great” impact on efforts to reduce readmissions. But three-fourths of those who responded said it is unfair that CMS fails to account for socioeconomic differences between hospital populations, and most felt the penalties were too large.
ACO Coalition
There’s still time to register for the fall meeting of the ACO and Emerging Healthcare Delivery Coalition, which meets two months from today in Philadelphia. Topics on the agenda include:
For information and to register, visit the meeting page.
For all of us at the Managed Markets News Network, I’m Justin Gallagher. Thanks for joining us.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More